|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+26.54% | -10.38% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
3dbc74ca2b839f4fb9a75fcd4d309560.H3NpkS6e2GsANHfXF3aoIhpPusylTlGdfT-_d3IrD78.VCobxUz_gjI1WDaWXiyedEkei47oAmHfJ33XIxB9d8ZFIjj9fOmCLXhzQw~20f365ce9243e36f136b8c735df85338
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +509.76% | |||
| +17.53% | |||||
| +19.92% | |||||
| +30.81% | |||||
| +97.89% | |||||
| +16.16% | |||||
| +26.43% | |||||
| -19.6% | |||||
| +15.31% | |||||
| -7.85% | |||||
| Average | +70.64% | |||||
| Weighted average by Cap. | +23.15% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1640USD
Average target price
1.000USD
Spread / Average Target
+509.76%
High Price Target
1.000USD
Spread / Highest target
+509.76%
Low Price Target
1.000USD
Spread / Lowest Target
+509.76%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1640USD
Average target price
1.000USD
Spread / Average Target
+509.76%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
- Consensus Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
